SCHEMBL8536320

SCHEMBL8536320

CC(C)C(O)S(=O)(=O)c1cc(Br)cnc1N

nearest known ligand 0.48

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.48
KMT2A Q03164 6/20 0.45
MEN1 O00255 5/20 0.45
ALDH1A1 P00352 1/20 0.44
KDM4E B2RXH2 2/20 0.43
HSD17B10 Q99714 2/20 0.43
SHMT2 P34897 1/20 0.42
PLA2G1B P04054 1/20 0.42
ATG4B Q9Y4P1 1/20 0.42
POLB P06746 1/20 0.41
HTT P42858 1/20 0.41
MAPT P10636 1/20 0.38
RAB9A P51151 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16996868 0.84 NPC1 (0.52) NPC1KMT2AMEN1ALDH1A1KDM4E
SCHEMBL857446 0.75 NPC1 (0.56) NPC1KMT2AMEN1ALDH1A1KDM4E
SCHEMBL859136 0.75 NPC1 (0.53) NPC1KMT2AMEN1ALDH1A1KDM4E
SCHEMBL855353 0.74 NPC1 (0.56) NPC1KMT2AMEN1ALDH1A1HSD17B10
SCHEMBL856675 0.74 NPC1 (0.59) NPC1KMT2AMEN1ALDH1A1KDM4E
SCHEMBL16461641 0.74 NPC1 (0.49) NPC1KMT2AMEN1ALDH1A1KDM4E
Hydrochloric Acid SCHEMBL27799005 0.74 NPC1 (0.51) NPC1KMT2AMEN1ALDH1A1KDM4E
SCHEMBL393051 0.73 KMT2A (0.57) NPC1KMT2AMEN1ALDH1A1KDM4E
SCHEMBL856801 0.72 NPC1 (0.45) NPC1KMT2AMEN1ALDH1A1KDM4E
SCHEMBL857534 0.72 NPC1 (0.45) NPC1KMT2AMEN1ALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2643317-A1 BENZOXAZEPINES AS INHIBITORS OF P13K/MTOR AND METHODS OF THEIR USE AND MANUFACTURE Exelixis, Inc. (US) 2013-10-02 EP disclosed
WO-2012071519-A1 BENZOXAZEPINES AS INHIBITORS OF P13K/MTOR AND METHODS OF THEIR USE AND MANUFACTURE EXELIXIS, INC. (US) 2012-05-31 WO disclosed